HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Seiler Selected Research

chemotactic factor inactivator

8/2013Clinical parameters associated with collateral development in patients with chronic total coronary occlusion.
10/2005Influence of diabetes mellitus on coronary collateral flow: an answer to an old controversy.
12/2001Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease.
10/2001Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study.
9/2001Quantitative contrast echocardiographic assessment of collateral derived myocardial perfusion during elective coronary angioplasty.
11/2000Quantitatively assessed coronary collateral circulation and restenosis following percutaneous revascularization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Seiler Research Topics

Disease

6Coronary Artery Disease (Coronary Atherosclerosis)
10/2005 - 02/2000
4Patent Foramen Ovale
03/2008 - 01/2001
4Pathologic Constriction (Stenosis)
12/2001 - 06/2000
2Neoplasms (Cancer)
01/2018 - 01/2000
2Myocardial Infarction
08/2013 - 12/2001
2Angina Pectoris
08/2013 - 12/2001
2Paradoxical Embolism
03/2008 - 02/2004
2Coronary Occlusion
10/2005 - 10/2001
2Adenocarcinoma
04/2005 - 01/2000
2Myocardial Ischemia (Ischemic Heart Diseases)
10/2001 - 06/2000
1Breast Neoplasms (Breast Cancer)
01/2018
1Triple Negative Breast Neoplasms
01/2018
1Hypertension (High Blood Pressure)
08/2013
1Erythema
04/2008
1Skin Diseases (Skin Disease)
04/2008
1Inert Gas Narcosis (Nitrogen Narcosis)
06/2001
1Embolism (Embolus)
04/2001
1Renal Insufficiency (Renal Failure)
07/2000
1Coronary Stenosis (Coronary Artery Stenosis)
06/2000
1Coronary Disease (Coronary Heart Disease)
04/2000
1Diastolic Heart Failure
03/2000

Drug/Important Bio-Agent (IBA)

6chemotactic factor inactivatorIBA
08/2013 - 11/2000
2HDL CholesterolIBA
12/2001 - 04/2000
1Proteins (Proteins, Gene)FDA Link
01/2018
1LigandsIBA
01/2018
1Threonine (L-Threonine)FDA Link
01/2018
1pimecrolimus (Elidel)FDA Link
04/2008
1Hydrocortisone (Cortisol)FDA LinkGeneric
04/2008
1Calcineurin InhibitorsIBA
04/2008
1Cisplatin (Platino)FDA LinkGeneric
04/2005
1InterferonsIBA
04/2005
1Fluorouracil (Carac)FDA LinkGeneric
04/2005
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2004
1Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA
12/2001
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
10/2001
1molgramostimIBA
10/2001
1Oxygen (Dioxygen)IBA
06/2001
1NitrogenIBA
06/2001
1nitroxIBA
06/2001
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
06/2001
1N 30IBA
11/2000
1Anti-Bacterial Agents (Antibiotics)IBA
07/2000
1Thromboxane A2 (A2, Thromboxane)IBA
06/2000
1CalciumIBA
06/2000
1NitratesIBA
06/2000
1Serotonin (5 Hydroxytryptamine)IBA
06/2000
1Vasodilator Agents (Vasodilators)IBA
06/2000
1sapropterin (tetrahydrobiopterin)FDA Link
02/2000
1procaine isothiocyanate (PRIT)IBA
01/2000
1Monoclonal AntibodiesIBA
01/2000

Therapy/Procedure

2Secondary Prevention
03/2008 - 04/2001
2Decompression
06/2001 - 01/2001
1Radiotherapy
04/2005
1Septal Occluder Device
02/2004
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2001
1Therapeutics
03/2000
1Radioimmunotherapy
01/2000